Science Explorer Back to mapMap
Discussion
Researcher · Centro Médico ABC · Mexico

Raquel Gerson-Cwilich

Raquel Gerson-Cwilich publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, on topics such as Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment and Lung Cancer Diagnosis and Treatment.

OpenAlex
World rank
#5,304,113
of 7,710,434 ranked researchers
Rank in Mexico
#24,637
of 55,557
Works
43
Citations
565
Citations per work
13.1
h-index
7
i10-index 5Top 78% in Oncology
Raquel Gerson-Cwilich

What does Raquel Gerson-Cwilich research?

Raquel Gerson-Cwilich's work is mostly in Medicine (51%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 22 works · 50.9% of their workMedicine: 22 works · 50.9% of their workOncology: 11 works · 26.2% of their workPulmonary and Respiratory Medicine: 6 works · 13.5% of their workObstetrics and Gynecology: 2 works · 5.6% of their workReproductive Medicine: 2 works · 5.6% of their workEverything else: 17 works · 40.3% of their workLife Sciences: 4 works · 8.8% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 8.8% of their workMolecular Biology: 2 works · 4.8% of their workGenetics: 2 works · 4.0% of their workTHEIR WORKRaquelGerson-Cwilich43works
Life Sciences9%Health Sciences51%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2250.9%
  2. Everything else1740.3%
    1. Biochemistry, Genetics and Molecular Biology48.8%
  1. 1Oncology26% of their works
  2. 2Pulmonary and Respiratory Medicine14% of their works
  3. 3Obstetrics and Gynecology6% of their works
  4. 4Reproductive Medicine6% of their works
  5. 5Molecular Biology5% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Raquel Gerson-Cwilich's research?

The keywords of their largest research topics: Metastasis, Chemotherapy, Clinical Trials, Immunotherapy, Targeted Therapy, Cancer of Unknown Primary, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Metastasis102 topics
  2. Chemotherapy92 topics
  3. Clinical Trials82 topics
  4. Immunotherapy82 topics
  5. Targeted Therapy82 topics
  6. Cancer of Unknown Primary61 topic
  7. Immune Checkpoint Blockade61 topic
  8. PD-1 and PD-L161 topic
  9. Tissue of Origin61 topic
  10. CT Screening51 topic
  11. Lung Cancer51 topic
  12. ALK Inhibitors41 topic
  13. CAR T Cells41 topic
  14. Cervical Cancer41 topic
  15. Chimeric Antigen Receptor41 topic
  16. Clinical Characteristics41 topic
  17. EGFR Mutations41 topic
  18. Endometrial Carcinoma41 topic
  19. Genomic Profiles41 topic
  20. SARS-CoV-241 topic
  21. Small-Cell Lung Cancer41 topic

Where does Raquel Gerson-Cwilich work?

Raquel Gerson-Cwilich's main affiliation in the publication record is Centro Médico ABC, Mexico.

How many publications and citations does Raquel Gerson-Cwilich have?

OpenAlex counts 43 works and 565 citations for Raquel Gerson-Cwilich, an h-index of 7, ranking #5,304,113 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Raquel Gerson-Cwilich

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Raquel Gerson-Cwilich. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.